After reviewing more than a dozen formularies, we noticed the following trends: Employer-sponsored benefit plans are the most likely to cover weight loss drugs, with a 2025 study showing that 19% of large firms and 43% of firms with 5,000 or more employees cover GLP-1 agonists
The result, of course, directly depends on regular competent training and adherence to certain nutritional rules: reduce daily calorie content by 500-1000 kcal per day, eat carbohydrates with a low glycemic index (only in the morning you can allow a small amount of sweet or starchy white flour), give up fast food
K.GrossmanY
Unlike GLP-1 and GLP-2, which have well-established functions and clinical applications, GLP-3 remains somewhat enigmatic in the scientific community
Melanotans action depends on how well it binds to these receptors and how the body responds
With so much talk, we connected with our experts to shed some light on the latest research and how these drugs affect heart health